THC

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended February 28, 1994, for National Medical Enterprises, Inc. (NME). The filing reflects a strategic pivot where the Company decided to discontinue its psychiatric hospital business and divest rehabilitation facilities to focus on core general hospital operations. The financial results are significantly impacted by the classification of the psychiatric division as discontinued operations and substantial legal settlements.

Key Financial Metrics

Note: Net loss is driven primarily by a $255 million estimated loss on disposal of psychiatric facilities and a $375 million reserve for government investigations recorded in discontinued operations.

Material Changes vs. Prior Period

• Revenue Decline: Net operating revenues decreased 9% ($74.4 million) for the quarter and 4% ($105.2 million) for the nine-month period compared to the prior year. This is primarily due to the sale of 28 rehabilitation hospitals and 45 outpatient clinics in January 1994.
• Profitability Shift: While continuing operations generated a profit of $90.7 million for the quarter (up from $65.1 million in the prior year), the Company reported a net loss of $164.3 million due to discontinued operations charges.
• Liquidity Improvement: Cash and cash equivalents increased by $209.9 million to $350.9 million, driven by proceeds from the sale of rehabilitation facilities ($260 million net) and the Hillhaven transaction ($135 million).
• Debt Restructuring: The Company refinanced its debt structure. In April 1994 (post-period), it entered a new $464.7 million credit agreement to replace term loans, securing covenant waivers related to litigation reserves.

Guidance, Outlook, and Risks

• Divestiture Strategy: The Company is executing a plan to dispose of substantially all psychiatric hospitals and substance abuse facilities. An agreement was signed in March 1994 to sell 47 psychiatric facilities to Charter Medical Corporation for approximately $200 million, with expected net cash proceeds of $186 million.
• Legal Contingencies: Significant reserves were recorded for unusual litigation costs. A $375 million reserve was added for federal and state government investigations regarding improper practices. The Company believes it has reached an agreement in principle to close federal investigations, but state resolutions are pending.
• Operational Outlook: Management expects continued pressure from health care reform, payor cost controls, and increased competition. However, general hospital operating profits have improved due to cost control programs and higher inpatient acuity.
• Dividend Restrictions: The new credit agreement restricts dividends to the lesser of $0.12 per share or 40% of consolidated net earnings (excluding specific litigation accruals).

Investor Verification Checklist

• Discontinued Operations Impact: Verify the final net cash proceeds from the sale of the 47 psychiatric facilities to Charter Medical Corporation against the estimated $186 million.
• Litigation Reserve Accuracy: Monitor the final settlement amounts for federal and state government investigations to ensure they do not exceed the $375 million reserve recorded.
• Debt Covenant Compliance: Confirm the Company's ability to meet the fixed charge coverage ratio (2.1 to 1) and net worth covenants under the new April 1994 credit agreement.
• Continuing Operations Margins: Assess whether the improved operating margins in general hospitals (13.2% for the quarter) are sustainable amidst rising Medicare/Medicaid discounts and managed care pressures.
• Share Count: Note that 165,952,065 shares were outstanding as of March 31, 1994, impacting per-share calculations for future earnings.